RU2073002C1 - Способ получения сульфонилпристинамицина iiв - Google Patents
Способ получения сульфонилпристинамицина iiв Download PDFInfo
- Publication number
- RU2073002C1 RU2073002C1 RU9192016441A RU92016441A RU2073002C1 RU 2073002 C1 RU2073002 C1 RU 2073002C1 RU 9192016441 A RU9192016441 A RU 9192016441A RU 92016441 A RU92016441 A RU 92016441A RU 2073002 C1 RU2073002 C1 RU 2073002C1
- Authority
- RU
- Russia
- Prior art keywords
- water
- oxidation
- tungstate
- thiopristinamycin
- diethylaminoethyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 8
- 230000015572 biosynthetic process Effects 0.000 title abstract description 15
- 238000003786 synthesis reaction Methods 0.000 title abstract description 14
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 15
- 230000003647 oxidation Effects 0.000 claims abstract description 14
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 claims abstract description 4
- -1 alkali metal tungstate Chemical class 0.000 claims description 27
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-Butanol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 229960003961 pristinamycin Drugs 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 8
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 7
- YVMBAUWDIGJRNY-BESUKNQGSA-N 4o8o7q7iu4 Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2CCC(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O YVMBAUWDIGJRNY-BESUKNQGSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 6
- 150000003457 sulfones Chemical class 0.000 description 5
- RLNUPSVMIYRZSM-UHFFFAOYSA-N Pristinamycin Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC(=CC=2)N(C)C)CCN(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O RLNUPSVMIYRZSM-UHFFFAOYSA-N 0.000 description 4
- 108010079780 Pristinamycin Proteins 0.000 description 4
- DAIKHDNSXMZDCU-OUDXUNEISA-N pristinamycin-IIA Natural products CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)C=C(C)C=CCNC(=O)C=C[C@@H]1C)n3 DAIKHDNSXMZDCU-OUDXUNEISA-N 0.000 description 4
- JOOMGSFOCRDAHL-XKCHLWDXSA-N pristinamycin-IIB Natural products CC(C)[C@@H]1OC(=O)[C@H]2CCCN2C(=O)c3coc(CC(=O)C[C@@H](O)C=C(C)C=CCNC(=O)C=C[C@H]1C)n3 JOOMGSFOCRDAHL-XKCHLWDXSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- CUCXXSBYLSQIJF-UHFFFAOYSA-N 1,1-dichloroethane;hydrate Chemical compound O.CC(Cl)Cl CUCXXSBYLSQIJF-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- FIMJSWFMQJGVAM-UHFFFAOYSA-N chloroform;hydrate Chemical compound O.ClC(Cl)Cl FIMJSWFMQJGVAM-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 1
- AAQNGTNRWPXMPB-UHFFFAOYSA-N dipotassium;dioxido(dioxo)tungsten Chemical compound [K+].[K+].[O-][W]([O-])(=O)=O AAQNGTNRWPXMPB-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Peptides Or Proteins (AREA)
- Electric Double-Layer Capacitors Or The Like (AREA)
- Heat Treatment Of Sheet Steel (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR909009033A FR2664597B1 (fr) | 1990-07-16 | 1990-07-16 | Procede de preparation de sulfonylpristinamycine iib. |
| FR9009033 | 1990-07-16 | ||
| PCT/FR1991/000579 WO1992001692A1 (fr) | 1990-07-16 | 1991-07-15 | Procede de preparation de sulfonylpristinamycine ii¿b? |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU92016441A RU92016441A (ru) | 1996-08-10 |
| RU2073002C1 true RU2073002C1 (ru) | 1997-02-10 |
Family
ID=9398751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU9192016441A RU2073002C1 (ru) | 1990-07-16 | 1991-07-15 | Способ получения сульфонилпристинамицина iiв |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5347001A (enExample) |
| EP (1) | EP0539484B1 (enExample) |
| JP (1) | JP3345811B2 (enExample) |
| KR (1) | KR100199068B1 (enExample) |
| AT (1) | ATE147744T1 (enExample) |
| AU (1) | AU654145B2 (enExample) |
| CA (1) | CA2082636C (enExample) |
| DE (1) | DE69124241T2 (enExample) |
| DK (1) | DK0539484T3 (enExample) |
| ES (1) | ES2095946T3 (enExample) |
| FI (1) | FI100884B (enExample) |
| FR (1) | FR2664597B1 (enExample) |
| GR (1) | GR3022284T3 (enExample) |
| IE (1) | IE912446A1 (enExample) |
| IL (1) | IL98851A (enExample) |
| NZ (1) | NZ238948A (enExample) |
| PT (1) | PT98334B (enExample) |
| RU (1) | RU2073002C1 (enExample) |
| TW (1) | TW197438B (enExample) |
| WO (1) | WO1992001692A1 (enExample) |
| ZA (1) | ZA915443B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2664598A1 (fr) * | 1990-07-16 | 1992-01-17 | Rhone Poulenc Rorer Sa | Procede de preparation de sulfinyl pristinamycine iib. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2576022B1 (fr) * | 1985-01-11 | 1987-09-11 | Rhone Poulenc Sante | Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent |
| GB8616768D0 (en) * | 1986-07-09 | 1986-08-13 | May & Baker Ltd | Process |
| GB2206577B (en) * | 1987-07-07 | 1990-10-24 | May & Baker Ltd | New process for the preparation of therapeutically useful pristinamycin iib sulphone derivatives |
| EP0322800A1 (en) * | 1987-12-25 | 1989-07-05 | Sumitomo Pharmaceuticals Company, Limited | Process for preparation of sulfone derivatives |
-
1990
- 1990-07-16 FR FR909009033A patent/FR2664597B1/fr not_active Expired - Lifetime
-
1991
- 1991-07-12 ZA ZA915443A patent/ZA915443B/xx unknown
- 1991-07-12 IE IE244691A patent/IE912446A1/en not_active IP Right Cessation
- 1991-07-12 NZ NZ238948A patent/NZ238948A/en not_active IP Right Cessation
- 1991-07-15 CA CA002082636A patent/CA2082636C/fr not_active Expired - Lifetime
- 1991-07-15 IL IL9885191A patent/IL98851A/xx not_active IP Right Cessation
- 1991-07-15 DE DE69124241T patent/DE69124241T2/de not_active Expired - Lifetime
- 1991-07-15 KR KR1019930700113A patent/KR100199068B1/ko not_active Expired - Lifetime
- 1991-07-15 DK DK91913608.5T patent/DK0539484T3/da active
- 1991-07-15 RU RU9192016441A patent/RU2073002C1/ru active
- 1991-07-15 EP EP91913608A patent/EP0539484B1/fr not_active Expired - Lifetime
- 1991-07-15 US US07/961,915 patent/US5347001A/en not_active Expired - Lifetime
- 1991-07-15 AT AT91913608T patent/ATE147744T1/de not_active IP Right Cessation
- 1991-07-15 WO PCT/FR1991/000579 patent/WO1992001692A1/fr not_active Ceased
- 1991-07-15 ES ES91913608T patent/ES2095946T3/es not_active Expired - Lifetime
- 1991-07-15 AU AU82221/91A patent/AU654145B2/en not_active Expired
- 1991-07-15 JP JP51234991A patent/JP3345811B2/ja not_active Expired - Lifetime
- 1991-07-16 PT PT98334A patent/PT98334B/pt not_active IP Right Cessation
- 1991-07-16 TW TW080105509A patent/TW197438B/zh not_active IP Right Cessation
-
1992
- 1992-12-11 FI FI925643A patent/FI100884B/fi not_active IP Right Cessation
-
1997
- 1997-01-16 GR GR960402521T patent/GR3022284T3/el unknown
Non-Patent Citations (1)
| Title |
|---|
| Патент Великобритании N 22065577, кл. C 07D 498/12, 1989. * |
Also Published As
| Publication number | Publication date |
|---|---|
| DK0539484T3 (da) | 1997-03-03 |
| PT98334B (pt) | 1999-01-29 |
| FI925643L (fi) | 1992-12-11 |
| FI100884B (fi) | 1998-03-13 |
| FI925643A0 (fi) | 1992-12-11 |
| IL98851A (en) | 1995-08-31 |
| DE69124241D1 (de) | 1997-02-27 |
| WO1992001692A1 (fr) | 1992-02-06 |
| IE912446A1 (en) | 1992-01-29 |
| AU8222191A (en) | 1992-02-18 |
| EP0539484B1 (fr) | 1997-01-15 |
| NZ238948A (en) | 1992-10-28 |
| ATE147744T1 (de) | 1997-02-15 |
| DE69124241T2 (de) | 1997-05-15 |
| ZA915443B (en) | 1993-03-31 |
| IL98851A0 (en) | 1992-07-15 |
| FR2664597A1 (fr) | 1992-01-17 |
| US5347001A (en) | 1994-09-13 |
| EP0539484A1 (fr) | 1993-05-05 |
| JP3345811B2 (ja) | 2002-11-18 |
| JPH05508651A (ja) | 1993-12-02 |
| KR100199068B1 (ko) | 1999-06-15 |
| KR930701449A (ko) | 1993-06-11 |
| FR2664597B1 (fr) | 1994-09-02 |
| ES2095946T3 (es) | 1997-03-01 |
| PT98334A (pt) | 1992-06-30 |
| GR3022284T3 (en) | 1997-04-30 |
| CA2082636C (fr) | 2002-05-21 |
| AU654145B2 (en) | 1994-10-27 |
| TW197438B (enExample) | 1993-01-01 |
| CA2082636A1 (fr) | 1992-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2577534C2 (ru) | Способ получения 2-гидроксибутиролактона | |
| HUT63404A (en) | Process for producing cyclic sulfate derivatives | |
| WO2001021617A1 (en) | Process for preparing sulfoxide compounds | |
| CN117658963A (zh) | 一种维生素c衍生物的非对映异构体及其制备和应用 | |
| KR101002795B1 (ko) | 신규한 레티닐 아스코르베이트 화합물 및 그 제조방법 | |
| US5347001A (en) | Process for preparing sulphonylpristinamycin IIB | |
| CS212343B2 (en) | Method of oxidation of penicillines | |
| KR19990037077A (ko) | 포르밀이미다졸의 제조 방법 | |
| EP0117861B1 (fr) | Procédé d'obtention de la vincristine | |
| EP0125654B1 (en) | Process for the preparation of especially pharmacologically active compounds containing a sulfoxide group | |
| US5272266A (en) | Vinylsulphonylpristinamycin and its preparation | |
| ATE540912T1 (de) | Verfahren zur ruthenium-katalysierten oxidation von alkoholen mit hypochlorit | |
| López et al. | Improvement of the synthesis of diphenylmethyl 7β-(o-hydroxy) benzylideneamino-3-hydroxymethyl-3-cephem-4-carboxylate | |
| US20030045751A1 (en) | Method for producing carboxylic acid by alcohol oxidation | |
| JPS60169493A (ja) | ５−デオキシ−ｌ−アラビノ−スの製造法 | |
| SU1616914A1 (ru) | Способ получени оксазиридинов | |
| SU290700A1 (ru) | Способ получени 2,2,6,6-тетраметил-4( -аминофенилсульфамидопиперидил-1-оксила) | |
| FI100971B (fi) | Menetelmä sultamisilliinivälituotteelle | |
| KR100238645B1 (ko) | 세팔로스포린 유도체의 새로운 에스테르화 방법 | |
| JP2000038383A (ja) | メバロラクトンの製造法 | |
| CH467245A (fr) | Procédé pour la préparation d'esters de la tétracycline, de la 7-chlorotétracycline et de la 5-hydroxytétracycline | |
| KR20010029475A (ko) | 약제학적 화합물의 제조 방법 | |
| RU1806134C (ru) | Трис-/2-оксиэтил/аммониева соль 3,4-дихлорфенилсульфонилуксусной кислоты в качестве стимул тора корнеобразовани | |
| SK180799A3 (en) | Method for producing calcium pyruvates | |
| Petrus et al. | Preparation of O-(3-azido-2-hydroxypropyl) cellulose and its photolysis to O-(2-formyl-2-hydroxyethyl) cellulose |